Fingerprint
Dive into the research topics of 'A randomized, open-label, phase 2, multicenter trial of gemcitabine with pazopanib or gemcitabine with docetaxel in patients with advanced soft-tissue sarcoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically